4.5 Article

Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease

期刊

NEUROBIOLOGY OF AGING
卷 35, 期 11, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.05.025

关键词

Parkinson's disease; LRRK2; p.R1441G; Asia; Intrafamilial clinical heterogeneity

资金

  1. Strategic Research Foundation
  2. KAKENHI [24390224, 25461290]
  3. Japanese Ministry of Education, Culture, Sports, Science and Technology [23111003, 25129707]
  4. Parkinson's Disease Foundation, United States
  5. National Institutes of Health, United States [R01 NS065070, P50 NS062684]
  6. Grants-in-Aid for Scientific Research [25461290] Funding Source: KAKEN

向作者/读者索取更多资源

Leucine-rich repeat kinase 2 (LRRK2) is a causative gene of autosomal dominant familial Parkinson's disease (PD). We screened for LRRK2 mutations in 3 frequently reported exons (31, 41, and 48) in our cohort of 871 Japanese patients with PD (430 with sporadic PD and 441 probands with familial PD). Direct sequencing analysis of LRRK2 revealed 1 proband (0.11%) with a p.R1441G mutation, identified for the first time in Asian countries, besides frequently reported substitutions including, the p.G2019S mutation (0.11%) and p.G2385R variant (11.37%). Several studies have suggested that the LRRK2 p.R1441G mutation, which is highly prevalent in the Basque country, is extremely rare outside of northern Spain. Further analysis of family members of the proband with the p.R1441G mutation revealed that her mother and first cousin shared the same mutation and parkinsonism. Haplotype analysis revealed a different haplotype from that of the original Spanish families. Our patients demonstrated levodopa-responsive parkinsonism with intrafamilial clinical heterogeneity. This is the first report of familial PD because of the LRRK2 p.R1441G mutation in Asia. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据